ACTRN12614001070628
Recruiting
N/A
The role of quantitative sensory testing parameters in predicting clinical outcome in patients undergoing lumbar discectomy
Dr Brigitte Tampin0 sites160 target enrollmentOctober 7, 2014
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Neurological - Other neurological disorders
- Sponsor
- Dr Brigitte Tampin
- Enrollment
- 160
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 to 65 years; symptom duration of \> 3 months; clinical diagnosis of lumbar radiculopathy (defined as conduction block along a spinal nerve or nerve root, manifesting clinically with dermatomal sensory loss or myotomal weakness or reflex changes) and leg pain in L5 or S1 dermatomal distribution; demonstrable clinically relevant abnormality on imaging studies indicating nerve root compression at the relevant spinal level; person listed on the elective neurosurgery surgery waitlist for the procedure of lumbar discectomy.
Exclusion Criteria
- •diabetes and vascular disease, thyroid disorder, other neurological or psychiatric disease; previous lumbar surgery; a history of any disorders that potentially might affect the sensation in the hand (negative control site) to be tested and an insufficient level of English to understand and fill out the questionnaires
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
*Characteristics of Quantitative Sensory Testing in ACNES patients compared to healthy controls; a pilot study.*abdominal wall painentrapment neuropathy10034606NL-OMON43275Maxima Medisch Centrum40
Active, Not Recruiting
Phase 1
Evaluation of sensory testing to measure the effects of tetrodotoxipainTherapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]CTIS2022-500318-24-00eiden University Medical Center25
Active, Not Recruiting
Phase 2
Tetrodotoxin and quantitative sensory testing in healthy volunteersPainSigns and SymptomsISRCTN78737401eiden University Medical Center25
Completed
N/A
Quantitative Sensory Testing (QST) as a tool to assess and quantify thoracic pain in patients with chronic interstitial lung disease (ILD)J84.9R07.4Interstitial pulmonary disease, unspecifiedChest pain, unspecifiedDRKS00022978niversitätsmedizin Essen, Ruhrlandklinik79
Recruiting
N/A
To study the role of Quantitative Sensory Testing in detection of Diabetic Neuropathy.CTRI/2012/07/002834A86